Biomedical Engineering - Technology Transfer and IP
A strong translational pipeline underlies the Biomedical Engineering Initiative to ensure rapid application of our innovations and protection of our devices.
- University Research & Enterprise Services has the role of identifying, protecting, developing and commercialising IP arising across the University. Our team of staff served expertise in both engineering and medical disciplines identify and evaluate the multiple opportunities and their eventual commercialisation.
- Triple Helix Model of Innovation followed at Newcastle creates a strong interdisciplinary environment for commercialisation and entrepreneurship in which the University provides knowledge of future technologies and clinical needs, Industry provides the productionisation and marketing knowledge, and Public Sector health providers address problems inherent in technology implementation.
- Newcastle Science City Initiative, Regional Development Agency (One North East) and Centres of Excellence provide strong links to the industrial sector. The Centre for Excellence in Life Sciences (CELS) coordinates the Healthcare Network, covering over 100 healthcare companies in NE England in the fields of assistive technology, biologics, health informatics and medical devices.
- Medical Physics, a joint NHS / University department, plays an important role in clinical evaluation, design and development of medical devices to the point of CE marking. It has an established history of delivering successful medical devices to the marketplace working with UK companies.
- Partnerships with Industry across the UK, EU and international arena provide a direct route to product. The University Commercial Development Team has a proven track record in the commercialisation of technologies through licensing, spin out (or start up) companies, joint ventures, and collaborations with established industry.
